|
| 34465468 | Hypoxia-inducible factor 1-alpha enhances the secretome to rejuvenate adult cardiosphere-derived cells. | J Thorac Cardiovasc Surg | 2023 |
| 37249624 | ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative. | Cancer Chemother Pharmacol | 2023 |
| 34465468 | Hypoxia-inducible factor 1-alpha enhances the secretome to rejuvenate adult cardiosphere-derived cells. | J Thorac Cardiovasc Surg | 2023 |
| 37249624 | ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative. | Cancer Chemother Pharmacol | 2023 |
| 35127495 | A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology. | Front Oncol | 2022 |
| 35847554 | Comparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury. | iScience | 2022 |
| 35127495 | A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology. | Front Oncol | 2022 |
| 35847554 | Comparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury. | iScience | 2022 |
| 33199836 | Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia. | Leukemia | 2021 |
| 33560385 | Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax. | Blood Adv | 2021 |
| 33199836 | Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia. | Leukemia | 2021 |
| 33560385 | Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax. | Blood Adv | 2021 |
| 31806659 | The PAX-SIX-EYA-DACH network modulates GATA-FOG function in fly hematopoiesis and human erythropoiesis. | Development | 2020 |
| 31806659 | The PAX-SIX-EYA-DACH network modulates GATA-FOG function in fly hematopoiesis and human erythropoiesis. | Development | 2020 |
| 30691681 | Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network. | Adv Cancer Res | 2019 |
| 30691681 | Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network. | Adv Cancer Res | 2019 |
| 31007002 | MicroRNAs as regulators and effectors of hematopoietic transcription factors. | Wiley Interdiscip Rev RNA | 2019 |
| 31007002 | MicroRNAs as regulators and effectors of hematopoietic transcription factors. | Wiley Interdiscip Rev RNA | 2019 |
| 29682185 | STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma. | Oncotarget | 2018 |
| 29361868 | Deterministic Lateral Displacement: The Next-Generation CAR T-Cell Processing? | SLAS Technol | 2018 |
| 29682185 | STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma. | Oncotarget | 2018 |
| 29845891 | A Fluidic Culture Platform for Spatially Patterned Cell Growth, Differentiation, and Cocultures. | Tissue Eng Part A | 2018 |
| 29845891 | A Fluidic Culture Platform for Spatially Patterned Cell Growth, Differentiation, and Cocultures. | Tissue Eng Part A | 2018 |
| 29361868 | Deterministic Lateral Displacement: The Next-Generation CAR T-Cell Processing? | SLAS Technol | 2018 |
| 28481221 | Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells. | J Clin Invest | 2017 |
| 28433605 | Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia. | Exp Hematol | 2017 |
| 28481221 | Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells. | J Clin Invest | 2017 |
| 28433605 | Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia. | Exp Hematol | 2017 |
| 26771236 | Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs. | Oncotarget | 2016 |
| 26965284 | MIM regulates the trafficking of bone marrow cells via modulating surface expression of CXCR4. | Leukemia | 2016 |
| 26771236 | Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs. | Oncotarget | 2016 |
| 26607595 | Inefficient megakaryopoiesis in mouse hematopoietic stem-progenitor cells lacking T-bet. | Exp Hematol | 2016 |
| 27875619 | Automated leukocyte processing by microfluidic deterministic lateral displacement. | Cytometry A | 2016 |
| 26607595 | Inefficient megakaryopoiesis in mouse hematopoietic stem-progenitor cells lacking T-bet. | Exp Hematol | 2016 |
| 27875619 | Automated leukocyte processing by microfluidic deterministic lateral displacement. | Cytometry A | 2016 |
| 26965284 | MIM regulates the trafficking of bone marrow cells via modulating surface expression of CXCR4. | Leukemia | 2016 |
| 25354783 | Identification of miR-145 targets through an integrated omics analysis. | Mol Biosyst | 2015 |
| 25828893 | c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated Leukemias. | Mol Cancer Res | 2015 |
| 25354783 | Identification of miR-145 targets through an integrated omics analysis. | Mol Biosyst | 2015 |
| 25312678 | MIR144 and MIR451 regulate human erythropoiesis via RAB14. | Br J Haematol | 2015 |
| 27274862 | Uncovering low-dimensional, miR-based signatures of acute myeloid and lymphoblastic leukemias with a machine-learning-driven network approach. | Converg Sci Phys Oncol | 2015 |
| 25213184 | Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic target. | Leuk Lymphoma | 2015 |
| 27274862 | Uncovering low-dimensional, miR-based signatures of acute myeloid and lymphoblastic leukemias with a machine-learning-driven network approach. | Converg Sci Phys Oncol | 2015 |
| 25828893 | c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated Leukemias. | Mol Cancer Res | 2015 |
| 25213184 | Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic target. | Leuk Lymphoma | 2015 |
| 25312678 | MIR144 and MIR451 regulate human erythropoiesis via RAB14. | Br J Haematol | 2015 |
| 24119518 | Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells. | Blood Cells Mol Dis | 2014 |
| 25368993 | Regulation of RAB5C is important for the growth inhibitory effects of MiR-509 in human precursor-B acute lymphoblastic leukemia. | PLoS One | 2014 |
| 24119518 | Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells. | Blood Cells Mol Dis | 2014 |
| 24415655 | Hepcidin-dependent and hepcidin-independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation. | Am J Hematol | 2014 |